COVID-19

The FDA granted emergency use authorization for an updated version of the COVID-19 vaccine manufactured by Novavax that targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2 virus.

In an analysis of deaths of patients with obesity but not diabetes from the SELECT trial, those assigned semaglutide 2.4 mg had reduced risk for death from COVID-19 compared with those assigned placebo.

One observed determinant of more resilience among French ICU professionals in the omicron wave was ICU experience during earlier waves, according to results published in American Journal of Respiratory and Critical Care Medicine.

Patients who received an mRNA COVID-19 vaccine demonstrated a 1.16-fold higher long-term risk for systemic lupus erythematosus, while a booster was linked to higher risk for psoriasis and rheumatoid arthritis, according to data.

Compared with 2019, in 2020, the first year of the COVID-19 pandemic, hospitalizations for acute MI were down but in-hospital mortality in that population rose in the U.S., researchers reported in the Korean Circulation Journal.

Nearly 10% of women infected with SARS-CoV-2 during pregnancy had post-acute sequelae 6 or more months later, according to results of the RECOVER-Pregnancy study published in Obstetrics & Gynecology.

Women with asymptomatic or mild COVID-19 infection at the time of frozen embryo transfer did not experience significant adverse early pregnancy outcomes, researchers reported in BMC Pregnancy and Childbirth.

ORLANDO, Fla. — A critical care nurse who served in a New York City ICU recounted how a commitment to lifelong learning helped her develop a treatment protocol that saved lives during the COVID-19 pandemic.